Klimek, L;Förster-Ruhrmann, U;Olze, H;Beule, A G;Chaker, A M;Hagemann, J;Huppertz, T;Hoffmann, T K;Dazert, S;Deitmer, T;Strieth, S;Wrede, H;Schlenter, W;Welkoborsky, H J;Wollenberg, B;Becker, S;Klimek, F;Sperl, A;Casper, I;Zuberbier, J;Rudack, C;Cuevas, M;Hintschich, C A;Guntinas-Lichius, O;Stöver, T;Bergmann, C;Pfaar, O;Gosepath, J;Gröger, M;Beutner, C;Laudien, M;Weber, R K;Hildenbrand, T;Hoffmann, A S;Bachert, C
[Not Available].
Laryngorhinootologie
2022
101
11
855-865

Klimek, L;Olze, H;Förster-Ruhrmann, U;Beule, A G;Chaker, A M;Hagemann, J;Huppertz, T;Hoffmann, T K;Dazert, S;Deitmer, T;Strieth, S;Wrede, H;Schlenter, W;Welkoborsky, H J;Wollenberg, B;Becker, S;Klimek, F;Zuberbier, J;Rudack, C;Cuevas, M;Hintschich, C A;Guntinas-Lichius, O;Stöver, T;Bergmann, C;Bachert, C
[Not Available].
Laryngorhinootologie
2022
101
4
284-294

Seiringer, P.;Hillig, C.;Schabitz, A.;Eyerich, S.;Fazekas, F.;Zouboulis, C. C.;Biedermann, T.;Eyerich, K.;Torocsik, D.
Sebaceous glands are actively and differentially involved in the pathogenesis of atopic dermatitis and psoriasis as revealed by spatial transcriptomics
J Invest Dermatol
2022
142 Suppl S
12
S186-S186

Bentz, Philipp;Eyerich, Kilian Georg;Weisshaar, Elke
The Molecular Classifier as a "game changer" in the Differential Diagnosis of Psoriasis and Eczema- News from the Heidelberg Cohort Study
J Dtsch Dermatol Ges
2022
20 Suppl 1
26-26

Mubarak, M.;Jargosch, M.;Hillig, C.;Menden, M.;Eyerich, K.;Eyerich, S.
The transcription factor CEBPB is a novel hub gene and multi-functional disease driver in skin inflammation
Exp Dermatol
2022
31
2
E46-E47

Klimek, Ludger;Foerster-Ruhrmann, Ulrike;Beule, Achim G.;Chaker, Adam M.;Hagemann, Jan;Klimek, Felix;Casper, Ingrid;Huppertz, Tilman;Hoffmann, Thomas K.;Dazert, Stefan;Deitmer, Thomas;Olze, Heidi;Strieth, Sebastian;Wrede, Holger;Schlenter, Wolfgang;Welkoborsky, Hans-Juergen;Wollenberg, Barbara;Bergmann, Christoph;Cuevas, Mandy;Beutner, Caroline;Groeger, Moritz;Becker, Sven
Documentation of biological therapies in chronic rhinosinusitis with nasal polyposis (CRSwNP): dupilumab, omalizumab and mepolizumab
Allergo J
2022
31
6
24-38

Bachert, Claus;Sousa, Ana R;Han, Joseph K;Schlosser, Rodney J;Sowerby, Leigh J;Hopkins, Claire;Maspero, Jorge F;Smith, Steven G;Kante, Oliver;Karidi-Andrioti, Despina E;Mayer, Bhabita;Chan, Robert H;Yancey, Steve W;Chaker, Adam M
Mepolizumab for chronic rhinosinusitis with nasal polyps: Treatment efficacy by comorbidity and blood eosinophil count.
J Allergy Clin Immunol
2022
149
5
1711-1721.e6

Siddiqui, Shahid;Bachert, Claus;Chaker, Adam M;Han, Joseph K;Hellings, Peter W;Peters, Anju T;Heffler, Enrico;Kamat, Siddhesh;Zhang, Haixin;Nash, Scott;Khan, Asif H;De Prado Gomez, Lucia;Jacob-Nara, Juby A;Rowe, Paul J;Deniz, Yamo
AROMA: real-world global registry of dupilumab for chronic rhinosinusitis with nasal polyps.
ERJ Open Res
2022
8
4

Busse, William W;Wellman, Andrew;Diamant, Zuzana;Cohen, Noam A;Chaker, Adam M;Bachert, Claus;Siddiqui, Shahid;Zhang, Haixin;Nash, Scott;Khan, Asif H;Jacob-Nara, Juby A;Rowe, Paul J;Deniz, Yamo
Impact of dupilumab on SNOT-22 sleep and function scores in CRSwNP.
J Allergy Clin Immunol Pract
2022
10
9
2479-2482.e3

Hellings, Peter W;Peters, Anju T;Chaker, Adam M;Heffler, Enrico;Zhang, Haixin;Praestgaard, Amy;Nash, Scott;Khan, Asif H;Siddiqui, Shahid;Jacob-Nara, Juby A;Rowe, Paul J;Deniz, Yamo
Rapid and sustained effects of dupilumab in severe chronic rhinosinusitis with nasal polyps.
Int Forum Allergy Rhinol
2022
12
7
958-962